Zins, K., Gunawardhana, S., Lucas, T., Abraham, D., & Aharinejad, S. (2013). Targeting Cdc42 with the small molecule drug AZA197 suppresses primary colon cancer growth and prolongs survival in a preclinical mouse xenograft model by downregulation of PAK1 activity. J Transl Med.

Zins, Karin, Sandun Gunawardhana, Trevor Lucas, Dietmar Abraham, and Seyedhossein Aharinejad. "Targeting Cdc42 With the Small Molecule Drug AZA197 Suppresses Primary Colon Cancer Growth and Prolongs Survival in a Preclinical Mouse Xenograft Model By Downregulation of PAK1 Activity." J Transl Med 2013.

Zins, Karin, et al. "Targeting Cdc42 With the Small Molecule Drug AZA197 Suppresses Primary Colon Cancer Growth and Prolongs Survival in a Preclinical Mouse Xenograft Model By Downregulation of PAK1 Activity." J Transl Med 2013.